002868 Lifecome Biochemistry
- 16.68
- +0.24+1.46%
Lifecome Biochemistry News
Lukang Biochemical: Progress Announcement on Providing Guarantees for Wholly-owned Subsidiaries
Lukang Biochemical: An indicative announcement on the expiration of the 2023 employee stock ownership plan for the first time and the first lockdown period for partially reserved shares
Lukang Biochemical: Announcement of Supervisory Board Resolutions
Lukang Biochemical: Announcement on Cancelling the 2023 Employee Stock Ownership Plan to Reserve Undistributed Shares
Lukang Biochemical: Report for the third quarter of 2024
Lukang Biochemical: Announcement of Board Resolutions
Lukang Biochemical: An indicative announcement on changes in the company\'s shares and equity by shareholders holding 5% or more of the shares by agreement
Lukang Biochemical: Simplified Equity Change Report (Baixing Real Estate)
Lukang Biochemical: Simplified Equity Change Report (Changxin No. 2)
Lukang Biochemical: Announcement on the controlling shareholder\'s partial share pledge
Lukang Biochemical: Announcement on the transfer registration of the company\'s shares by agreement of shareholders holding 5% or more of the shares
Lukang Biochemical: Announcement of Resolutions of the 6th (Interim) Meeting of the Fifth Board of Directors
Lukang Biochemical: Announcement on the company applying for a loan from a bank using its own assets as collateral
Lukang Biochemical: Announcement on the cancellation of the pledge of some shares of the controlling shareholder
Lukang Biochemical: Announcement on the release of collateral for the company\'s own assets
Lukang Biochemical: Announcement on the controlling shareholder\'s partial share pledge
Lukang Biochemical: An indicative announcement on changes in the company\'s shares and equity by shareholders holding 5% or more of the shares by agreement
Lukang Biochemical: Simplified Equity Change Report (Hangzhou Yirui)
Lukang Biochemical: Simplified Equity Change Report (Hangzhou Haoyi)
Lukang Biochemical: 2024 Semi-Annual Report Summary
Analysis
Price Target
No Data
No Data